Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial

JAMA Neurology
Carl E ClarkePD REHAB Collaborative Group

Abstract

It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-effective in Parkinson disease (PD). To perform a large pragmatic randomized clinical trial to evaluate the clinical effectiveness of individualized physiotherapy and occupational therapy in PD. The PD REHAB Trial was a multicenter, open-label, parallel group, controlled efficacy trial. A total of 762 patients with mild to moderate PD were recruited from 38 sites across the United Kingdom. Recruitment took place between October 2009 and June 2012, with 15 months of follow-up. Participants with limitations in activities of daily living (ADL) were randomized to physiotherapy and occupational therapy or no therapy. The primary outcome was the Nottingham Extended Activities of Daily Living (NEADL) Scale score at 3 months after randomization. Secondary outcomes were health-related quality of life (assessed by Parkinson Disease Questionnaire-39 and EuroQol-5D); adverse events; and caregiver quality of life. Outcomes were assessed before trial entry and then 3, 9, and 15 months after randomization. Of the 762 patients included in the study (mean [SD] age, 70 [9.1] years), 381 received physiotherapy and occupational therapy and 381 received n...Continue Reading

Citations

Dec 23, 2016·The International Journal of Neuroscience·Danique L M RadderNienke M de Vries
Jul 12, 2017·The Journal of the American Academy of Orthopaedic Surgeons·Joseph F BakerR Shay Bess
Mar 24, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Susan H FoxUNKNOWN Movement Disorder Society Evidence-Based Medicine Committee
Aug 17, 2019·Expert Review of Neurotherapeutics·Martijn L T M MüllerNicolaas I Bohnen
Nov 6, 2017·Journal of Parkinson's Disease·Valeria StuderGiuseppe Frazzitta
Jun 3, 2016·Physical Therapy·Alan M Jette
Nov 16, 2019·OTJR : Occupation, Participation and Health·Whitney HendersonJaquelyn Bliss
Jan 20, 2017·Current Neurology and Neuroscience Reports·Shen-Yang LimSoon Chai Low
May 15, 2018·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Imre CikajloKarmen Peterlin Potisk
Sep 8, 2016·Neurodegenerative Disease Management·Seyed-Mohammad Fereshtehnejad
Sep 15, 2020·Journal of Parkinson's Disease·Sabine SchootemeijerBastiaan R Bloem
Nov 30, 2019·Parkinson's Disease·Michele FranciottaGiuseppe Frazzitta
Feb 20, 2020·Arquivos de neuro-psiquiatria·Ana Cristina TillmannAdriana Coutinho de Azevedo Guimarães
Jun 23, 2016·Archives of Physiotherapy·Daniele Piscitelli
May 11, 2018·Current Opinion in Neurology·Jaime KulisevskySusan H Fox
Aug 21, 2018·Frontiers in Neurology·Lauren E HeusinkveldDavid Charles
Nov 14, 2020·Neurorehabilitation and Neural Repair·Stanislaw SolnikDaniele Piscitelli
Feb 23, 2021·Current Neurology and Neuroscience Reports·Miriam R RaffertyJillian MacDonald
Jun 29, 2021·Neuroscience Letters·Wagner Antonio Barbosa da SilvaClynton Lourenço Correa
Jan 1, 2020·Physiotherapy Canada. Physiothérapie Canada·Asterie TwizeyemariyaSteven Milanese

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.